- Home
- IMMX vs GRVY Comparison
IMMX vs GRVY Comparison
Compare IMMX & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMMX | GRVY |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.0M | 426.5M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | IMMX | GRVY |
|---|---|---|
| Price | $8.84 | $63.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $19.20 | N/A |
| AVG Volume (30 Days) | ★ 675.4K | 25.5K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.87 | $54.54 |
| 52 Week High | $11.61 | $74.75 |
Technical Indicators
Market Signals| Indicator | IMMX | GRVY |
|---|---|---|
| Relative Strength Index (RSI) | 42.64 | 50.96 |
| Support Level | $8.15 | $62.73 |
| Resistance Level | $8.97 | $65.34 |
| Average True Range (ATR) | 0.74 | 1.88 |
| MACD | -0.10 | 0.03 |
| Stochastic Oscillator | 17.72 | 40.94 |
Price Performance
Historical ComparisonAbout IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.